FDA Approves First Influenza Vaccine for Self-Administration
The nasal spray flu vaccine is available for self- or caregiver-administration by prescription for individuals aged 2 to 49.
Tag: FluMist influenza vaccine
FDA Approves First Influenza Vaccine for Self-Administration
The nasal spray flu vaccine is available for self- or caregiver-administration by prescription for individuals aged 2 to 49.
Read More
FDA to Review FluMist Nasal Spray Influenza Vaccine
A supplemental biologics application for AstraZeneca’s FluMist Quadrivalent is currently being reviewed by the FDA. If approved, FluMist would be the first needle-free, nasal spray influenza vaccine available to be self-administered by patients or caregivers.Â
Read More